Literature DB >> 31553287

A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes.

Gagan D Flora1, Manasa K Nayak1.   

Abstract

Cardiovascular diseases (CVDs) are the leading cause of premature death and disability in humans and their incidence is on the rise globally. Given their substantial contribution towards the escalating costs of health care, CVDs also generate a high socio-economic burden in the general population. The underlying pathogenesis and progression associated with nearly all CVDs are predominantly of atherosclerotic origin that leads to the development of coronary artery disease, cerebrovascular disease, venous thromboembolism and, peripheral vascular disease, subsequently causing myocardial infarction, cardiac arrhythmias or stroke. The aetiological risk factors leading to the onset of CVDs are well recognized and include hyperlipidaemia, hypertension, diabetes, obesity, smoking and, lack of physical activity. They collectively represent more than 90% of the CVD risks in all epidemiological studies. Despite high fatality rate of CVDs, the identification and careful prevention of the underlying risk factors can significantly reduce the global epidemic of CVDs. Beside making favorable lifestyle modifications, primary regimes for the prevention and treatment of CVDs include lipid-lowering drugs, antihypertensives, antiplatelet and anticoagulation therapies. Despite their effectiveness, significant gaps in the treatment of CVDs remain. In this review, we discuss the epidemiology and pathology of the major CVDs that are prevalent globally. We also determine the contribution of well-recognized risk factors towards the development of CVDs and the prevention strategies. In the end, therapies for the control and treatment of CVDs are discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Atherosclerosis; epidemiological studies; hypertension; platelets; stroke; thrombosis.

Mesh:

Year:  2019        PMID: 31553287     DOI: 10.2174/1381612825666190925163827

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  40 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

2.  Early myocardial injury biomarkers in diabetic hyperlipidemic rats: Impact of 10-dehydrogingerdione and vitamin D3.

Authors:  Mohamed M Elseweidy; Sousou I Aly; Sally K Hammad; Noura I Shershir
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-19

3.  ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative study.

Authors:  Andrew P Andonopoulos; Neoklis Georgopoulos; Dimitrios Daoussis; Panagiotis Kordas; George Varelas; Marina Michalaki; Anny Onoufriou; Irene Mamali; George Iliopoulos; Konstantinos Melissaropoulos; Konstantinos Ntelis; Dimitrios Velissaris; Giannis Tzimas; Panagiotis Georgiou; Sofia Vamvakopoulou; Fotini Paliogianni
Journal:  Rheumatol Int       Date:  2022-04-21       Impact factor: 2.631

4.  Correlation of ApoE gene polymorphism with acute myocardial infarction and aspirin resistance after percutaneous coronary intervention.

Authors:  Luoqing Wang; Chen Shao; Cuimin Han; Peng Li; Feixiang Wang; Yilian Wang; Junping Li
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 5.  Role of Posttranslational Modifications of Proteins in Cardiovascular Disease.

Authors:  Yong-Ping Liu; Tie-Ning Zhang; Ri Wen; Chun-Feng Liu; Ni Yang
Journal:  Oxid Med Cell Longev       Date:  2022-07-09       Impact factor: 7.310

6.  Dynamic Changes in Red Cell Distribution Width Can Predict Major Adverse Cardiovascular Events after PCI in Patients with Unstable Angina Pectoris: A Retrospective Cohort Study.

Authors:  Qiang Xiao; Dekai Yan; Jian Qin; Wenwen Chen; Ke Jiang; Jian Zhao; Chen Zhang; Yuanmin Li
Journal:  Dis Markers       Date:  2022-06-08       Impact factor: 3.464

7.  A Coronary Artery Disease Monitoring Model Built from Clinical Data and Alpha-1-Antichymotrypsin.

Authors:  Chen-Chi Chang; I-Jung Tsai; Wen-Chi Shen; Hung-Yi Chen; Po-Wen Hsu; Ching-Yu Lin
Journal:  Diagnostics (Basel)       Date:  2022-06-08

8.  Structural, functional, and mechanistic insights uncover the fundamental role of orphan connexin-62 in platelets.

Authors:  Khaled A Sahli; Gagan D Flora; Parvathy Sasikumar; Ali H Maghrabi; Lisa-Marie Holbrook; Sarah K AlOuda; Amro Elgheznawy; Tanya Sage; Alexander R Stainer; Recep Adiyaman; Mohammad AboHassan; Marilena Crescente; Neline Kriek; Sakthivel Vaiyapuri; Alexander P Bye; Amanda J Unsworth; Chris I Jones; Liam J McGuffin; Jonathan M Gibbins
Journal:  Blood       Date:  2021-02-11       Impact factor: 22.113

9.  Correlation between serum lipid and prognosis of idiopathic sudden sensorineural hearing loss: a prospective cohort study.

Authors:  Minmin Shao; Guofeng Xiong; Guangzao Xiang; Shile Xu; Liqun Zhang
Journal:  Ann Transl Med       Date:  2021-04

10.  A new model for COVID-19 control and its implementation in the city of Honghu, China: a case report.

Authors:  He-Ran Wang; Meng-Chun Gong; Jing-Yuan Sun; Jian Sun; Yi Guo; Li Liu; Hong Zhu
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-25       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.